Harter Secrest & Emery LLP (HSE), a full-service business law firm with offices throughout New York, recently represented Athenex, Inc. (Nasdaq: ATNX) in a public offering of 10,000,000 shares of Athenex common stock.  The underwriters were also granted an over-allotment option to purchase 1,500,000 additional shares of Athenex common stock. The HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Sarah H. Brennan, C. Christopher Murillo, and Ryan A. Whelpley

Founded in 2003 in Buffalo, NY, Athenex is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Their mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company has operations across the U.S., China, Hong Kong, Taiwan, the U.K., and Latin America. Athenex intends to use the net proceeds from the proposed offering to continue to expand and strengthen its commercial infrastructure, execute label expansion strategies for Oral Paclitaxel, advance the development of its product candidates, invest in its chemistry, manufacturing and controls development for its product candidates and manufacturing infrastructure, and fund working capital and other general corporate purposes.

Harter Secrest & Emery is recognized as a leader in the securities and capital markets industry. With 10 attorneys devoted to practicing securities and capital markets law in western New York, the firm brings a depth and breadth of experience unmatched in the region. The firm has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. HSE’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, and securities litigation and arbitration before the Securities and Exchange Commission, NYSE, Nasdaq, FINRA, and state and federal courts.

click here to view Harter Secrest & Emery Advises Athenex, Inc. in Connection with $110 Million Public Offering as a PDF

Disclaimer

This website presents only general information not intended as legal advice. Although we encourage calls, letters and emails from prospective clients, please keep in mind that merely contacting Harter Secrest & Emery LLP (HSE) does not establish an attorney-client relationship between us. Confidential information should not be sent to HSE until you have been notified in writing by HSE that a formal attorney-client relationship has been established. Information sent to us before then may not be treated as confidential by HSE or the court.

I have read this and agree     Cancel

Our website uses cookies. By continuing to use our site, you agree to our use of cookies in accordance with our Privacy Policy.